Page last updated: 2024-12-07

n,n-bis(2-hydroxyethyl)-4-toluidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N,N-bis(2-hydroxyethyl)-4-toluidine: lysosome stabilizing agent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID76497
CHEMBL ID3189033
SCHEMBL ID33921
MeSH IDM0115836

Synonyms (56)

Synonym
ethanol, 2,2'-[(4-methylphenyl)imino]bis-
unii-r00stp10pr
r00stp10pr ,
ethanol,2'-[(4-methylphenyl)imino]bis-
n-(4-methylphenyl)-n,n-diethanolamine
n,n-di(2-hydroxyethyl)-para-toluidine
nsc-103354
n,n-bis(2-hydroxyethyl)-p-toluidine
nsc103354
diethylol-p-toluidine
ethanol,2'-(p-tolylimino)di-
n,n-diethanol-p-toluidine
n-(4-methylphenyl)diethanolamine
3077-12-1
2,2'-(p-tolylimino)diethanol
2,2'-(4-methylphenylimino)diethanol, technical grade, 90%
n,n-bis(2-hydroxyethyl)-4-toluidine
ethanol, 2,2'-(p-tolylimino)di-
2,2'-((4-methylphenyl)imino)bisethanol
n,n-(2-hydroxyethyl)-p-toluidine
ethanol, 2,2'-((4-methylphenyl)imino)bis-
nsc 103354
einecs 221-359-1
ccris 814
2,2'-(4-methylphenylimino)diethanol, >=97.0% (nt)
2,2'-(4-methylphenylimino)diethanol
p-tolyldiethanolamine
T2455
2,2'-[(4-methylphenyl)imino]diethanol
T0797
2-[n-(2-hydroxyethyl)-4-methylanilino]ethanol
dtxcid8024650
cas-3077-12-1
tox21_302653
NCGC00256693-01
dtxsid0044650 ,
AKOS015966710
FT-0609142
2,2'-(p-tolylazanediyl)diethanol
dihydroxyethyl toluidine
dihydroxyethyl toluidine [inci]
2,2'-((4-methylphenyl)imino)diethanol
n-(p-tolyl)diethanolamine
SCHEMBL33921
n,n-dihydroxyethyl-p-toluidine
Q-201426
CHEMBL3189033
mfcd00020580
H11776
30771-20-1
4-tolyldiethanolamine
DS-4665
2,2'-[(4-methylphenyl)imino]bisethanol
CS-W010620
Q27287588
?2,2'-(p-tolylimino)diethanol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency68.58960.001022.650876.6163AID1224838; AID1224893
estrogen nuclear receptor alphaHomo sapiens (human)Potency48.97820.000229.305416,493.5996AID743075
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.13800.023723.228263.5986AID743223
aryl hydrocarbon receptorHomo sapiens (human)Potency61.13060.000723.06741,258.9301AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency9.68850.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency27.30600.001628.015177.1139AID1259385
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency13.68540.000323.4451159.6830AID743067
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (9.09)18.7374
1990's3 (27.27)18.2507
2000's3 (27.27)29.6817
2010's4 (36.36)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.54 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (9.09%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]